MinettaCLiuMD

Oncology • Rochester, MN

Mayo Clinic

Join to view full profile

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Liu's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511
Is this information wrong?

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995

Certifications & Licensure

MN State Medical License 2013 - 2024
DC State Medical License 1997 - 2013
American Board of Internal Medicine Medical Oncology

Clinical Trials

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer Start of enrollment: 2001 Apr 01
Terminated
Phase 2
Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer Start of enrollment: 2000 Oct 01
Completed
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Recruiting
Phase 2
Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
Completed
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women Start of enrollment: 2014 Mar 11
Completed
Phase 2
A Safety Study of SGN-LIV1A in Breast Cancer Patients Start of enrollment: 2013 Oct 22
Completed
Phase 1
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer Start of enrollment: 2019 Sep 16
Suspended
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice Start of enrollment: 2019 Dec 12
Completed
Not Applicable
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer Start of enrollment: 2020 Sep 23
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments.
Sung Mi Yoon, Jeeyeon Lee, Joo Hee Park, Soowon Lee, Timothy Hong, Liam Il-Young Chung, Sumedha Sudhaman, Timothy Riddell, Charuta C Palsuledesai, Young Kwang Chae, Yo...> ;Thoracic Cancer. 2024 Apr 1
1 citations
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early...
Aaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, Kevin L M Chua, Angela Takano, Boon-Hean Ong, Tina P T Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesva...> ;Cancer. 2024 Feb 29
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Fernando Recio, Carly Bess Scalise, Paul Loar, Melissa Lumish, Tara Berman, Abhinand Peddada, Ekaterina Kalashnikova, Samuel Rivero-Hinojosa, Tricia Beisch, Brittany N...> ;Gynecologic Oncology. 2024 Mar 1
Early real-world experience monitoring circulating tumor DNA in resected early-stage non-small cell lung cancer.
Martin, T., Dinerman, A., Sudhaman, S., Budde, G., Palsuledesai, C., Smith, E., Tapias, L., Podgaetz, E., Krainock, M., Liu, M., Schwartz, G.> ;The Journal of Thoracic and Cardiovascular Surgery. 2024 Jan 18
1 citations
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial.
Gallagher, R., Wulfkuhle, J., Wolf, D., Brown-Swigart, L., Yau, C., O'Grady, N., Basu, A., Lu, R., Campbell, M., Magbanua, M., Coppé, J., , Asare, S., Sit, L., Matthew...> ;Cell Reports. Medicine. 2023 Dec 19
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.
Ekaterina Kalashnikova, Vasily N Aushev, Allyson Koyen Malashevich, Antony Tin, Shifra Krinshpun, Raheleh Salari, Carly Bess Scalise, Rosalyn Ram, Meenakshi Malhotra, ...> ;Molecular Oncology. 2023 Dec 1
3 citations
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.
Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, George Laliotis, Philippe Lamy, Emil Christensen, Derrick Renner, Tine G Andreasen, Naja Lange, Shruti Sh...> ;Clinical Cancer Research. 2023 Dec 1
5 citations
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.
Bruna Pellini, Russell W Madison, Merrida A Childress, Shoshana T Miller, Ole Gjoerup, Jason Cheng, Richard S P Huang, Michael Krainock, Pratyush Gupta, Wei Zou, David...> ;Clinical Cancer Research. 2023 Nov 14
2 citations
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial).
Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, Lilja B Solnes, Rita Denbow, Vandana G Abramson, Lisa A Carey, Minetta C Liu, Mothaffar Rimawi, Jennifer Specht, Ann...> ;Journal of Nuclear Medicine. 2023 Nov 1
10 citations
Practical recommendations for using ctDNA in clinical decision making.
Stacey A Cohen, Minetta C Liu, Alexey Aleshin> ;Nature. 2023 Jul 1
1 citations
Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.
Eric A Klein, Sarina Madhavan, Tomasz M Beer, Chetan Bettegowda, Minetta C Liu, Anne-Renee Hartman, Allan Hackshaw> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 Aug 1
Dying to Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era.
Eric A Klein, Sarina Madhavan, Tomasz M Beer, Chetan Bettegowda, Minetta C Liu, Anne-Renee Hartman, Allan Hackshaw> ;Cancer Epidemiology, Biomarkers & Prevention. 2023 May 15
10 citations
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen...> ;Cancer Cell. 2023 Jun 12
6 citations
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
Jodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W Hillman, Kathleen S Tenner, Jennifer M Kachergus, Heather Ann Brauer, ...> ;Nature Communications. 2023 Apr 18
8 citations
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.
Tufia C Haddad, Vera J Suman, Antonino B D'Assoro, Jodi M Carter, Karthik V Giridhar, Brendan P McMenomy, Katelyn Santo, Erica L Mayer, Meghan S Karuturi, Aki Morikawa...> ;JAMA Oncology. 2023 Jun 1
Reply to S. Chakrabarti and A. Mahipal.
Brandon M Huffman, Adham Jurdi, Alexey Aleshin, Minetta C Liu, Samuel J Klempner> ;JCO Precision Oncology. 2023 Mar 1
1 citations
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast c...
Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, A Jo Chien, Judy C Boughey, Hyo S Han, Anne Wallace, Heather Beckwith, Minetta C Liu, Christina Yau, E Paul Wile...> ;Breast Cancer Research and Treatment. 2023 Apr 1
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Emily S Lebow, Narek Shaverdian, Jordan E Eichholz, Leah B Kratochvil, Megan McCune, Yonina R Murciano-Goroff, Justin Jee, Juliana Eng, Jamie E Chaft, Mark G Kris, Eka...> ;Frontiers in Oncology. 2023 Jan 1
25 citations
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Susana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, Benjamin J Kelly, Ana C Garrido-Castro, Tomas Pascual, Aguirre A De Cubas, Youli Xia, Brooke M Felsheim, Marn...> ;Nature Cancer. 2023 Jan 1
2 citations
Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
Maggie Zhou, Nam Bui, Richa Rathore, Sumedha Sudhaman, Giby V George, Allyson K Malashevich, Meenakshi Malhotra, Minetta C Liu, Alexey Aleshin, Kristen N Ganjoo> ;Cancers. 2022 Dec 27
6 citations
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Er...> ;NPJ Breast Cancer. 2022 Dec 1
60 citations
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Arash Jamshidi, Minetta C Liu, Eric A Klein, Oliver Venn, Earl Hubbell, John F Beausang, Samuel Gross, Collin Melton, Alexander P Fields, Qinwen Liu, Nan Zhang, Eric T...> ;Cancer Cell. 2022 Dec 12
Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options.
Spencer H Shao, Brian Allen, Jessica Clement, Gina Chung, Jingjing Gao, Earl Hubbell, Minetta C Liu, Charles Swanton, W H Wilson Tang, Habte Yimer, Mohan Tummala> ;Tumori. 2023 Jun 1
7 citations
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with animmunostimulatory bacterial transgene.
Kimberly B Viker, Michael B Steele, Ianko D Iankov, Susanna C Concilio, Arun Ammayappan, Brad Bolon, Nathan J Jenks, Matthew P Goetz, Eleni Panagioti, Mark J Federspie...> ;Molecular Therapy. Methods & Clinical Development. 2022 Sep 8
3 citations
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Grace M Choong, Savannah Liddell, Roberto A Leon Ferre, Ciara C O'Sullivan, Kathryn J Ruddy, Tufia C Haddad, Timothy J Hobday, Prema P Peethambaram, Minetta C Liu, Mat...> ;Breast Cancer Research and Treatment. 2022 Nov 1
Join now to see all

Abstracts/Posters

Molecular Alterations in Adult Histiocytic Neoplasms
Minetta C Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Genome-wide cell-free DNA (cfDNA) methylation signatures and effect on tissue of origin (TOO) performance.
2019 ASCO Annual Meeting - 6/1/2019
Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Applications of Liquid Biopsies in Metastatic Breast Cancer
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Join now to see all

Press Mentions

Natera Announces New Signatera™ MRD Data at 2023 AACR Annual MeetingApril 14th, 2023
Colorectal Cancer: New Blood Test May Help Determine if Chemotherapy Is Needed After SurgeryJanuary 18th, 2023
Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera's Ability to Predict Chemotherapy Benefit in Colorectal CancerJanuary 17th, 2023
Join now to see all